survivin antigen
Term · Oncology and biomedicine · MLC-T-ONC-016920
A tumor-associated antigen. Vaccination with survivin antigen may result in a cytotoxic T-cell response against survivin antigen-expressing tumor cells, resulting in decreased tumor cell proliferation and tumor cell death. Overexpressed in many tumors, endogenous survivin inhibits tumor cell apoptosis.
| Identifier | MLC-T-ONC-016920 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | SRV |
| Synonyms | survivin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016920",
"term": "survivin antigen",
"field": "Oncology and biomedicine",
"definition": "A tumor-associated antigen. Vaccination with survivin antigen may result in a cytotoxic T-cell response against survivin antigen-expressing tumor cells, resulting in decreased tumor cell proliferation and tumor cell death. Overexpressed in many tumors, endogenous survivin inhibits tumor cell apoptosis.",
"abbreviation": "SRV",
"synonyms": [
"survivin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/survivin-antigen/"
}
Record 15,831 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.